Perspectives from the clinic: Will the average physician embrace personalized medicine?

Research output: Contribution to journalShort surveypeer-review

Abstract

In 1961, Richard Asher argued that the clinical question regarding a particular intervention is not "should it work?" but rather "does it work?". 1,2,3 Since that time, clinical trials have become the cornerstone of clinical science, providing physicians access to an expanding pharmacopeia of therapeutic options. The new capacity to change the course of illness has transformed patients' lives as well as the clinical encounter. The recent call for personalized medicine is an attempt to further our therapeutic effectiveness.

Original languageEnglish (US)
Pages (from-to)492-493
Number of pages2
JournalClinical pharmacology and therapeutics
Volume83
Issue number3
DOIs
StatePublished - Mar 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Perspectives from the clinic: Will the average physician embrace personalized medicine?'. Together they form a unique fingerprint.

Cite this